Cure Blindness Project Releases Record-Breaking 2025 Impact Report

Published on June 2, 2026
NORWICH, Vt.—Cure Blindness Project has released its 2025 Impact Report, highlighting a record-breaking year in the organization’s global effort to eliminate avoidable blindness. This report captures a period of unprecedented research and impact, according to the Cure Blindness Project, which includes more than 315,000 sight-restoring surgeries delivered across the organization’s global network, representing more than 1 percent of the world’s cataract blindness. “It is always a true honor to announce our results. On behalf of our team and all our partners, we are excited and proud to share what we’ve accomplished together,” said K-T Overbey, CEO of Cure Blindness Project.
Continue reading on website
Other news

Chlogan Eyewear Appoints Michael Shavitz as Vice President of Sales

June 2, 2026
HICKSVILLE, N.Y.—Chlogan Eyewear, an independent, family-owned eyewear company, has announced the appointment of Michael Shavitz as vice president of sales. In his new role, Shavitz will be responsible for developing, advancing, and executing Chlogan Eyewear’s national sales strategy, with a focus on expanding distribution channels and strengthening the company’s reach among independent eyecare pr

Zeiss Invests in Maculaser to Advance Temperature-Controlled Retinal Laser Therapy

June 2, 2026
OBERKOCHEN, Germany—Zeiss Ventures, the corporate venture capital arm of the Zeiss Group, has announced its participation in the latest funding round of Maculaser, a Finnish medtech company developing a non-damaging, temperature-controlled retinal laser therapy. The funding round, co-led by Zeiss Ventures and M2care, will support Maculaser’s plan to initiate clinical development for its personaliz